Viewing Study NCT04355494


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-25 @ 11:45 PM
Study NCT ID: NCT04355494
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2021-03-09
First Post: 2020-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SOLIRISĀ® (Eculizumab) Treatment of Participants With COVID-19
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module